➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Boehringer Ingelheim
Harvard Business School
Merck
McKesson

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

SIMPONI ARIA Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for SIMPONI ARIA

Identify potential brand extensions & biosimilar entrants

SponsorPhase
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
University of South FloridaPhase 2
University of Erlangen-Nürnberg Medical SchoolPhase 3

See all SIMPONI ARIA clinical trials

Recent Litigation for SIMPONI ARIA

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
ABBVIE INC. v. SANDOZ INC.2018-08-10
Celgene Corporation v. Aurobindo Pharma Limited2018-07-06
AMGEN INC. v. EMCURE PHARMACEUTICALS LTD.2018-06-28

See all SIMPONI ARIA litigation

PTAB Litigation
PetitionerDate
2017-12-20

See all SIMPONI ARIA litigation

Pharmacology for SIMPONI ARIA

Patent Text Search: US Patents for SIMPONI ARIA

These patents were identified by searching patent claims

Supplementary Protection Certificates for SIMPONI ARIA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
17C1057 France   Try Before You Buy PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: EU/1/17/1196 20170627
PA2020505 Lithuania   Try Before You Buy PRODUCT NAME: UPADACITINIBAS; REGISTRATION NO/DATE: EU/1/19/1404 20191216
C201730049 Spain   Try Before You Buy PRODUCT NAME: SARILUMAB; NATIONAL AUTHORISATION NUMBER: EU/1/17/1196; DATE OF AUTHORISATION: 20170623; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1196; DATE OF FIRST AUTHORISATION IN EEA: 20170623
CR 2017 00061 Denmark   Try Before You Buy PRODUCT NAME: SARILUMAB; REG. NO/DATE: EU/1/17/1196/001-8 20170627
300911 Netherlands   Try Before You Buy PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: EU/1/17/1196 20170627
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Medtronic
AstraZeneca
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.